ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Mycology |
Manuscript Type |
Minireviews |
Article Title |
Purpureocillium lilacinum: A minireview
|
Manuscript Source |
Invited Manuscript |
All Author List |
Daisuke Usuda, Daiki Furukawa, Rikako Imaizumi, Rikuo Ono, Yuki Kaneoka, Eri Nakajima, Yuto Sugawara, Runa Shimizu, Riki Sakurai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, Sakurako Ito, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Tomohisa Nomura and Manabu Sugita |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
The Japan Society for the Promotion of Science KAKENHI Grant |
No. 24K15491 |
|
Corresponding Author |
Daisuke Usuda, Associate Professor, MD, PhD, Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima 177-8521, Tokyo, Japan. d.usuda.qa@juntendo.ac.jp |
Key Words |
Purpureocillium lilacinum; Hyalohyphomycosis; Immunocompromised status; Identification; Treatment; Minireview |
Core Tip |
Purpureocillium lilacinum (formerly Paecilomyces lilacinus) is a hyaline hyphomycete with a ubiquitous distribution. In the last decade this fungus has been increasingly found as the causal agent of an emerging opportunistic pathogen, which can cause a wide spectrum of clinical manifestations, especially among immuno-compromised patients or following surgical procedures. The pathogenic mechanisms are not yet fully understood. Early and accurate species identification and susceptibility testing are vital. In general, surgical debridement combined with antifungal drug therapy, or the correction of predisposing factors, are usually required to obtain improvement. |
Publish Date |
2025-08-28 09:39 |
Citation |
<p>Usuda D, Furukawa D, Imaizumi R, Ono R, Kaneoka Y, Nakajima E, Sugawara Y, Shimizu R, Sakurai R, Matsubara S, Tanaka R, Suzuki M, Shimozawa S, Hotchi Y, Osugi I, Katou R, Ito S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Nomura T, Sugita M. Purpureocillium lilacinum: A minireview. <i>World J Clin Cases</i> 2025; 13(29): 108582</p> |
URL |
https://www.wjgnet.com/2307-8960/full/v13/i29/108582.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v13.i29.108582 |